Previous Page  2 / 12 Next Page
Information
Show Menu
Previous Page 2 / 12 Next Page
Page Background

allied

academies

Page 33

Notes:

Journal of Neurology and Neurorehabilitation Research | Volume 4

November 04-05, 2019 | Melbourne, Australia

Neurology and Neurological Disorders

19

th

International Conference on

J Neurol Neurorehabil Res, Volume 4

Repetitive Transcranial Magnetic Stimulation improves Depressive symptoms and

quality of life of Poststroke patients - Prospective case series study

Hercílio Barbosa da Silva Júnior

Neuronus Institute, Brazil

Poststrokedepression(PSD)isaseriouspsychiatriccomplication

often reported after a stroke. Nearly a third of stroke survivors

experience depressive symptoms at some point, affecting their

functional recovery andquality of life. In recent years, repetitive

transcranial magnetic stimulation (rTMS) has been studied by

many researchers and found to be a safe supporting tool for

the treatment of PSD.

Objective:

We aim to evaluate the effects of rTMS on PSD and

on the quality of life of poststroke patients.

Method:

A prospective clinical case series, performed at CRER

Rehabilitation, Brazil, between June 2016 and May 2017. A

nonprobabilistic sample (n=15) was divided into 2 groups

(excitatory stimulation in F3, n=8; inhibitory stimulation in

F4, n=7) and underwent 20 sessions of rTMS. Individuals

were assessed according to the 17-item Hamilton Depression

Rating Scale (HAM-D17) and World Health Organization

Quality of Life-Brief Version (WHOQOL-BREF) questionnaire

at 3 different moments: baseline, at the end of the treatment,

and in a 1-month follow-up meeting.

Results:

Both groups presented a significant change in the

score of all WHOQOL-BREF domains and in HAM-D17. In

the group that received inhibitory stimulation (F4), score

changes were continuous and gradual, comparing the 3

moments. In the excitatory stimulated (F3) group, however,

the improvement in scores was more expressive between

baseline and the secondmoment, without significant changes

in the follow-up.

Conclusions:

The findings of this clinical study suggest that

rTMS can be a promising tool, capable of relieving depressive

symptoms and helping in the improvement of poststroke

patients’ quality of life.

Speaker Biography

HercilioBarbosadaSilvaJuniorisaPsychologist(2004)andNeuropsychologist

(2008) and he has a Master degree in Health Sciences from the Federal

University of Goiás, Brazil (2017). He worked in a huge local rehabilitation

center for almost 6 years (2011-2016), where he helped to implant the

Neuromodulation Lab in 2013. Since then he research non-invasive brain

stimulation techniques (rTMS and tDCS) in the treatment of neurological

disorders (mood, memory and language recovery after stroke or traumatic

brain injuries), psychiatric disorders (anxiety and mood disorders) and

learning disorders (ADD and ADHD). He is the founder director of the

Neuronus Institute for Trans-disciplinary Brain Studies located in Goiânia,

Goiás, Brazil, where he is based.

e:

hercilio@neuronus.com.br